Back to GetFilings.com



Table of Contents



UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


Form 10-Q

     
(Mark One)
   
þ
  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the Quarterly Period Ended July 31, 2003
 
or
 
o
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the transition period from           to

Commission file number 000-27999


Finisar Corporation

(Exact name of Registrant as specified in its charter)
     
Delaware
  94-3038428
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
 
1308 Moffett Park Drive
Sunnyvale, California
(Address of principal executive offices)
  94089
(Zip Code)

Registrant’s telephone number, including area code:

408-548-1000

Common Stock, $.001 par value

(Title of Class)


     Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes þ          No o

     Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).     Yes þ          No o

     At August 18, 2003, there were 212,667,563 shares of the registrant’s common stock, $.001 par value, issued and outstanding.




TABLE OF CONTENTS

PART I -- FINANCIAL INFORMATION
Item 1. Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Item 4. Controls And Procedures.
PART II -- OTHER INFORMATION
Item 1. Legal Proceedings
Item 2. Changes in Securities and Use of Proceeds
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
EXHIBIT 31.1
EXHIBIT 31.2
EXHIBIT 32.1
EXHIBIT 32.2


Table of Contents

INDEX TO QUARTERLY REPORT ON FORM 10-Q

For the Quarter Ended July 31, 2003
             
Page

PART I FINANCIAL INFORMATION        
Item 1.
  Financial Statements:        
    Condensed Consolidated Balance Sheets as of July 31, 2003 and April 30, 2003     2  
    Condensed Consolidated Statements of Operations for the three month periods ended July 31, 2003 and 2002     3  
    Condensed Consolidated Statements of Cash Flows for the three month periods ended July 31, 2003 and 2002     4  
    Notes to Condensed Consolidated Financial Statements     6  
Item 2.
  Management’s Discussion and Analysis of Financial Condition and Results of Operations     22  
Item 3.
  Quantitative and Qualitative Disclosure About Market Risk     41  
Item 4.
  Controls and Procedures     41  
PART II OTHER INFORMATION        
Item 1.
  Legal Proceedings     42  
Item 2.
  Changes in Securities and Use of Proceeds     42  
Item 6.
  Exhibits and Reports on Form 8-K     43  
Signatures     44  

1


Table of Contents

PART I — FINANCIAL INFORMATION

 
Item 1. Financial Statements

FINISAR CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

                   
July 31, 2003 April 30, 2003


(In thousands, except share
and per share data)
ASSETS
Current assets:
               
 
Cash and cash equivalents
  $ 28,967     $ 40,918  
 
Short-term investments
    79,509       78,520  
 
Restricted investments
    6,732       6,737  
 
Accounts receivable, trade (net)
    25,660       23,390  
 
Accounts receivable, other
    4,536       5,362  
 
Inventories
    29,697       36,470  
 
Prepaid expenses
    2,651       2,341  
 
Deferred income taxes
    3,069       3,324  
     
     
 
Total current assets
    180,821       197,062  
Property, plant, equipment and improvements, net
    100,989       112,125  
Restricted investments, long-term
    3,308       3,307  
Purchased intangibles, net
    48,111       52,910  
Goodwill, net
    19,985       19,838  
Minority investments
    26,167       28,844  
Other assets
    9,307       9,520  
     
     
 
Total assets
  $ 388,688     $ 423,606  
     
     
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
               
 
Accounts payable
  $ 21,396     $ 22,872  
 
Accrued compensation
    3,933       4,449  
 
Other accrued liabilities
    10,391       8,474  
 
Non-cancelable purchase obligations
    9,711       9,380  
 
Income tax payable
    806       536  
 
Current portion of other long-term liabilities
    1,384       1,384  
     
     
 
Total current liabilities
    47,621       47,095  
Long-term liabilities:
               
 
Deferred income taxes
    3,069       3,324  
 
Convertible notes, net of unamortized portion of beneficial conversion feature of $28,604 and $30,977 at July 31, 2003 and April 30, 2003, respectively
    91,396       94,023  
 
Other long-term liabilities
    4,192       4,184  
     
     
 
Total long-term liabilities
    98,657       101,531  
Stockholders’ equity
               
 
Common stock, $0.001 par value, 210,285,954 shares issued and outstanding at July, 31, 2003 and 207,295,693 shares issued and outstanding at April 30, 2003.
    210       207  
 
Additional paid-in capital
    1,226,996       1,219,424  
 
Notes receivable from stockholders
    (934 )     (1,077 )
 
Deferred stock compensation
    (674 )     (1,045 )
 
Accumulated other comprehensive income
    1,407       841  
 
Accumulated deficit
    (984,595 )     (943,370 )
     
     
 
Total stockholders’ equity
    242,410       274,980  
     
     
 
Total liabilities and stockholders’ equity
  $ 388,688     $ 423,606  
     
     
 

See accompanying notes.

2


Table of Contents

FINISAR CORPORATION

 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                   
Three Months Ended
July 31,

2003 2002


(Unaudited, in thousands,
except per share data)
Revenues
  $ 39,431     $ 47,047  
Cost of revenues
    36,462       36,923  
Amortization of acquired developed technology
    4,656       7,395  
     
     
 
Gross profit (loss)
    (1,687 )     2,729  
Operating expenses:
               
 
Research and development
    20,915       15,516  
 
Sales and marketing
    4,300       6,156  
 
General and administrative
    3,953       3,850  
 
Amortization of deferred stock compensation
    (304 )     1,381  
 
Amortization of purchased intangibles
    143       329  
 
Impairment of goodwill and intangible assets
          485  
 
Restructuring costs
    2,185        
 
Other acquisition costs
    45       197  
     
     
 
Total operating expenses
    31,237       27,914  
     
     
 
Loss from operations
    (32,924 )     (25,185 )
Interest income
    869       1,404  
Interest expense
    (6,377 )     (2,745 )
Other expense, net
    (2,580 )     (10,338 )
     
     
 
Loss before income taxes and cumulative effect of an accounting change
    (41,012 )     (36,864 )
Provision for income taxes
    213       61  
     
     
 
Loss before cumulative effect of an accounting change
    (41,225 )     (36,925 )
Cumulative effect of an accounting change to adopt SFAS 142.
          (460,580 )
     
     
 
Net loss
  $ (41,225 )   $ (497,505 )
     
     
 
Loss per share before cumulative effect of an accounting change
  $ (0.20 )   $ (0.19 )
Cumulative per share effect of an accounting change to adopt SFAS 142
          (2.44 )
     
     
 
Loss per share — basic and diluted
  $ (0.20 )   $ (2.63 )
     
     
 
Shares used in loss per share calculation — basic and diluted
    206,744       189,424  
     
     
 

See accompanying notes.

3


Table of Contents

FINISAR CORPORATION

 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                     
Three Months Ended
July 31,

2003 2002


(Unaudited, in thousands)
Operating Activities:
               
Net loss
  $ (41,225 )   $ (497,505 )
Adjustments to reconcile net loss to net cash used in operating activities:
               
   
Depreciation and amortization
    11,804       4,358  
   
Amortization of deferred stock compensation
    (304 )     1,381  
   
Amortization of purchased intangibles
    143       329  
   
Amortization of acquired developed technology
    4,656       7,395  
   
Amortization of beneficial conversion feature
    2,373       1,134  
   
Loss on conversion of convertible notes
    2,412        
   
Pro-rate share of losses in a minority investment (equity method)
    204       185  
   
Cumulative effect of an accounting change
          460,580  
   
Amortization of premium discount on restricted securities
    4       (206 )
   
Other than temporary decline in market value of marketable security
    528        
   
Impairment of minority investment
    1,631       10,000  
   
Impairment of goodwill and intangible assets
          485  
   
Other non-cash charges
    607        
     
     
 
   
Total non-cash adjustment in operating activities
    24,058       485,641  
     
     
 
Changes in operating assets and liabilities:
               
   
Accounts receivable
    (2,270 )     (6,064 )
   
Inventories
    6,773       995  
   
Other assets
    452       1,367  
   
Accounts payable
    (1,171 )     (11,874 )
   
Accrued compensation
    (516 )     (3,200 )
   
Current income taxes
          (37 )
   
Other accrued liabilities
    2,526       3,054  
     
     
 
   
Total change in operating assets and liabilities
    5,794       (15,759 )
     
     
 
 
Net cash used in operating activities
    (11,373 )     (27,623 )
Investing activities:
               
Purchases of property, plant, equipment and improvements
    (1,405 )     (5,289 )
Sale/(purchase) of short-term investments
    (989 )     (4,196 )
Purchase of minority investments, net of loan repayments
    842       (155 )
Acquisition of product line assets
          (243 )
     
     
 
Net cash used in investing activities
    (1,552 )     (9,883 )
Financing activities:
               
Payments on capital lease obligations
          (180 )
Payment received on stockholder note receivable
    109       127  
Proceeds from exercise of stock options and stock purchase plan net of repurchase of unvested shares
    865       1,576  
     
     
 

4


Table of Contents

                   
Three Months Ended
July 31,

2003 2002


(Unaudited, in thousands)
Net cash provided by financing activities
    974       1,523  
     
     
 
Net decrease in cash and cash equivalents
    (11,951 )     (35,983 )
Cash and cash equivalents at beginning of period
    40,918       75,889  
     
     
 
Cash and cash equivalents at end of period
  $ 28,967     $ 39,906  
     
     
 
Supplemental disclosure of cash flow information:
               
 
Cash paid for interest
  $ 72     $ 5  
 
Cash paid for taxes
  $ 207     $ 61  
Supplemental schedule of non-cash investing and financing activities:
               
 
Issuance of other long term liabilities in connection with acquisition of product line
  $     $ 5,384  
 
Issuance of common stock in connection with acquisitions
  $     $ 485  
 
Issuance of common stock upon conversion of convertible notes
  $ 7,412     $ 6,750  
 
Issuance of common stock on achievement of milestones
  $ 147     $  

See accompanying notes.

5


Table of Contents

FINISAR CORPORATION

 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

1.     Summary of Significant Accounting Policies

 
Description of Business

      Finisar Corporation was incorporated in the state of California on April 17, 1987. In November 1999, Finisar Corporation reincorporated in the state of Delaware.

      Finisar Corporation designs, manufactures, and markets fiber optic subsystems and components and network test and monitoring systems for high-speed data communications.

 
Interim Financial Information and Basis of Presentation

      The accompanying unaudited condensed consolidated financial statements as of July 31, 2003, and for the three month periods ended July 31, 2003 and 2002, have been prepared in accordance with accounting principles generally accepted in the United States for interim financial statements and pursuant to the rules and regulations of the Securities and Exchange Commission, and include the accounts of Finisar Corporation and its wholly-owned subsidiaries (collectively, “Finisar” or the “Company”). Intercompany accounts and transactions have been eliminated in consolidation. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of the Company’s financial position at July 31, 2003 and its operating results and cash flows for the three month periods ended July 31, 2003 and 2002. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and notes for the fiscal year ended April 30, 2003.

      The balance sheet at April 30, 2003 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.

 
Fiscal Periods

      The Company maintains its financial records on the basis of a fiscal year ending on April 30, with fiscal quarters ending on the Sunday closest to the end of the period (thirteen-week periods). For ease of reference, all references to period end dates have been presented as though the period ended on the last day of the calendar month. The first three quarters of fiscal 2003 end on July 28, 2002, October 27, 2002 and January 26, 2003, respectively, and the first three quarters of fiscal 2004 end on July 27, 2003, October 26, 2003 and January 25, 2004, respectively.

 
Use of Estimates

      The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.

 
Revenue Recognition

      The Company follows SEC Staff Accounting Bulletin (SAB) No. 101, “Revenue Recognition in Financial Statements.” Specifically, the Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. Product revenue is generally recorded at the time of shipment when title and risk of loss pass to the customer, unless the Company has future unperformed obligations or customer

6


Table of Contents

FINISAR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

acceptance is required, in which case revenue is not recorded until such obligations have been satisfied or customer acceptance has been received.

      At the time revenue is recognized, the Company establishes an accrual for estimated warranty expenses associated with sales, recorded as a component of cost of revenues. The Company also provides an allowance for estimated customer returns, which has been netted against revenues.

 
Segment Reporting

      Statement of Financial Accounting Standards No. 131, “Disclosures about Segments of an Enterprise and Related Information” (“SFAS 131”) establishes standards for the way that public business enterprises report information about operating segments in annual financial statements and requires that those enterprises report selected information about operating segments in interim financial reports. SFAS 131 also establishes standards for related disclosures about products and services, geographic areas, and major customers. The Company has determined that it operates in two segments consisting of optical subsystems and components, and network test and monitoring systems.

 
Concentrations of Credit Risk

      Financial instruments which potentially subject Finisar to concentrations of credit risk include cash, cash equivalents, short-term and restricted investments and accounts receivable. Finisar places its cash, cash equivalents and short-term and restricted investments with high-credit quality financial institutions. Such investments are generally in excess of FDIC insurance limits. Concentrations of credit risk, with respect to accounts receivable, exist to the extent of amounts presented in the financial statements. In many instances, the Company sells to contract manufacturers for the ultimate end customer equipment supplier. Generally, Finisar does not require collateral or other security to support customer receivables. Finisar performs periodic credit evaluations of its customers and maintains an allowance for potential credit losses based on historical experience and other information available to management. Losses to date have been within management’s expectations. At April 30, 2003, one optical subsystems and components customer represented 10.3% of total accounts receivable. At July 31, 2003, one optical subsystems and components customer represented 10.0% of total accounts receivable. No other customer represented more than 10.0% of total accounts receivable in either period.

 
Current Vulnerabilities Due to Certain Concentrations

      Finisar sells products primarily to customers located in North America. During the three months ended July 31, 2003, revenues from three optical subsystems and components customers represented 16.3%, 11.2% and 10.4%, respectively, of revenues. During the three months ended July 31, 2002, revenues from one optical subsystems and components customer accounted for 10.1% of net revenues. No other customer accounted for more than 10.0% of revenues in either period.

 
Foreign Currency Translation

      The functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate on the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the year. Any translation adjustments resulting from this process are included as a component of accumulated other comprehensive income. Foreign currency transaction gains and losses are included in the determination of net loss.

7


Table of Contents

FINISAR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
Research and Development

      Research and development expenditures are charged to operations as incurred.

 
Advertising Costs

      Advertising costs are expensed as incurred. Advertising is used infrequently in marketing the Company’s products. Advertising costs were $46,000 and $196,000 in the three months ended July 31, 2003 and 2002, respectively.

 
Cash and Cash Equivalents

      Finisar’s cash equivalents consist of money market funds and highly liquid short-term investments with qualified financial institutions. Finisar considers all highly liquid investments with an original maturity from the date of purchase of three months or less to be cash equivalents.